Informed Consent for Whole Genome Sequencing

Insights from Paul Appelbaum, MD, Columbia University Medical Center

Date
Wednesday, January 29, 2014
Time
Noon
Description
Whole genome and whole exome sequencing are becoming prevalent tools in clinical medicine and medical research. Dr. Paul Applebaum will explore possible new models of informed patient consent that will be needed in this emerging field. Applebaum, former president of the American Psychiatric Association, is one of the world’s leading experts on informed consent in medicine.
Contact
316-4650, possorio@morgridge.org